Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA vs Corticosteroids for ICI-induced Cholestatic Hepatitis
NCT07378761Phase 2Recruiting
- Sponsor
- CHU Montpellier
- Start
- Jun 2026
- Primary completion
- Jan 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ursodeoxycholic acid in cholestasis, sponsored by CHU Montpellier. Started Jun 2026; status: recruiting.
02
Drugs
ursodeoxycholic acid
03
Conditions
cholestasis
Beyond the preview
Go deeper on NCT07378761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07378761.